{"title":"Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Colorectal Cancer of Biparatopic HER2-targeting ADC JSKN003","path":"/2026/02/14/alphamab-oncology-announces-the-first-patient-dosed-in-a-phase-iii-clinical-study-for-colorectal-cancer-of-biparatopic-her2-targeting-adc-jskn003/","site":"https://laotiantimes.com","atUri":"at://did:plc:svcthvzunxmjidtlw23zva6n/site.standard.document/3meu27t25ood2","publishedAt":"2026-02-14T12:58:00Z","tags":"Cision PR Newswire"}